{"id":"https://openalex.org/W4408097435","doi":"https://doi.org/10.21203/rs.3.rs-6096098/v1","title":"Exploring Temporal and Spatial Characteristics of Serious Adverse Event Reports Following COVID-19 Bivalent Vaccines","display_name":"Exploring Temporal and Spatial Characteristics of Serious Adverse Event Reports Following COVID-19 Bivalent Vaccines","publication_year":2025,"publication_date":"2025-03-03","ids":{"openalex":"https://openalex.org/W4408097435","doi":"https://doi.org/10.21203/rs.3.rs-6096098/v1","pmid":"https://pubmed.ncbi.nlm.nih.gov/40092435","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11908350"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-6096098/v1","doi":"https://doi.org/10.21203/rs.3.rs-6096098/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-6096098/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.21203/rs.3.rs-6096098/v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113134285","display_name":"Yiming Li","orcid":"https://orcid.org/0009-0009-8784-1745","observed_orcids":["https://orcid.org/0009-0009-8784-1745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiming Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100660697","display_name":"Wei Tao","orcid":"https://orcid.org/0000-0002-4277-3728","observed_orcids":["https://orcid.org/0000-0002-4277-3728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Tao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076389057","display_name":"Yifang Dang","orcid":"https://orcid.org/0000-0002-4014-2957","observed_orcids":["https://orcid.org/0000-0002-4014-2957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yifang Dang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100454438","display_name":"Yong Chen","orcid":"https://orcid.org/0000-0003-0835-0788","observed_orcids":["https://orcid.org/0000-0003-0835-0788","https://orcid.org/0009-0009-7123-8044"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024491202","display_name":"Cui Tao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cui Tao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.4562999904155731,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11819","display_name":"Data-Driven Disease Surveillance","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.9470000267028809},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.9480000138282776},{"id":"https://openalex.org/keywords/temporal-trends","display_name":"temporal trends","score":0.6420000195503235},{"id":"https://openalex.org/keywords/spatial-distribution","display_name":"spatial distribution","score":0.6959999799728394},{"id":"https://openalex.org/keywords/regional-variation","display_name":"regional variation","score":0.6740000247955322},{"id":"https://openalex.org/keywords/post-licensure-surveillance","display_name":"post-licensure surveillance","score":0.7480000257492065},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.6549999713897705},{"id":"https://openalex.org/keywords/vaers","display_name":"VAERS","score":0.6359999775886536},{"id":"https://openalex.org/keywords/temporal-analysis","display_name":"temporal analysis","score":0.34299999475479126},{"id":"https://openalex.org/keywords/spatial-analysis","display_name":"spatial analysis","score":0.9020000100135803}],"concepts":[{"id":"https://openalex.org/C2776620830","wikidata":"https://www.wikidata.org/wiki/Q4919211","display_name":"Bivalent (engine)","level":3,"score":0.8851994276046753},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7819603681564331},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7060542702674866},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5333538055419922},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5091397166252136},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.4993140697479248},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.43033039569854736},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.428475558757782},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3758409321308136},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23081731796264648},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.18068817257881165},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.163764089345932},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.14700889587402344},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.14585471153259277},{"id":"https://openalex.org/C544153396","wikidata":"https://www.wikidata.org/wiki/Q11426","display_name":"Metal","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.21203/rs.3.rs-6096098/v1","doi":"https://doi.org/10.21203/rs.3.rs-6096098/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-6096098/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmid:40092435","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40092435","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research square","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:10724506","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11908350","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:11908350","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11908350","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Res Sq","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-6096098/v1","doi":"https://doi.org/10.21203/rs.3.rs-6096098/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-6096098/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8399999737739563,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G4276235123","display_name":"Dynamic learning for post-vaccine event prediction using temporal information in VAERS","funder_award_id":"R01AI130460","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000915926","display_name":"VIOLIN 2.0: Vaccine Information and Ontology LInked kNowledgebase","funder_award_id":"U24AI171008","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W2944400536","https://openalex.org/W3103134232","https://openalex.org/W3111255098","https://openalex.org/W3111602384","https://openalex.org/W3120106258","https://openalex.org/W3121036322","https://openalex.org/W3155354002","https://openalex.org/W3161834201","https://openalex.org/W3185563517","https://openalex.org/W4281619994","https://openalex.org/W4293740214","https://openalex.org/W4296026861","https://openalex.org/W4308365541","https://openalex.org/W4309698067","https://openalex.org/W4318016227","https://openalex.org/W4321004604","https://openalex.org/W4380323684","https://openalex.org/W4389481977","https://openalex.org/W4392468106","https://openalex.org/W4393063345","https://openalex.org/W4398758564","https://openalex.org/W4401440681","https://openalex.org/W4404391730","https://openalex.org/W4407246683","https://openalex.org/W4407722649"],"related_works":["https://openalex.org/W7140830198","https://openalex.org/W4398758564","https://openalex.org/W4410190671","https://openalex.org/W4408277690","https://openalex.org/W4403585163","https://openalex.org/W4392190516","https://openalex.org/W4308451505","https://openalex.org/W3193909907","https://openalex.org/W3210009951","https://openalex.org/W3207775422"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"To":[2,94],"mitigate":[3],"the":[4,14,39,56,65,74,107,123,131,166,202,211,219],"spread":[5],"of":[6,18,29,52,76,98,109,125,163,174,186,223],"variants":[7],"such":[8],"as":[9],"Omicron":[10],"in":[11,114,151],"COVID-19":[12,19,40,77,179,224],"pandemic,":[13],"development":[15],"and":[16,61,64,83,158,168,214,221],"utilization":[17],"bivalent":[20,41,78,180,225],"vaccines":[21,79],"have":[22],"become":[23],"essential.":[24],"However,":[25],"an":[26,49],"expected":[27],"subset":[28],"individuals":[30],"may":[31],"experience":[32],"serious":[33,116],"adverse":[34,117],"events":[35],"(AE)":[36],"after":[37],"receiving":[38],"vaccine.":[42,181],"Methods":[43],"In":[44,161],"this":[45],"research,":[46],"we":[47,101],"conducted":[48],"in-depth":[50],"analysis":[51,104,215],"data":[53],"obtained":[54],"from":[55],"Centers":[57],"for":[58,91,205,217],"Disease":[59],"Control":[60],"Prevention":[62],"(CDC)":[63],"Vaccine":[66],"Adverse":[67],"Event":[68],"Reporting":[69],"System":[70],"(VAERS)":[71],"to":[72,105],"evaluate":[73],"safety":[75,220],"administered":[80],"between":[81],"9/15/2022":[82],"9/1/2023.":[84],"The":[85],"Standard":[86],"Federal":[87],"Regions":[88],"were":[89],"used":[90],"region":[92],"partitions.":[93],"broaden":[95],"our":[96,199],"understanding":[97],"post-vaccination":[99],"AE,":[100],"performed":[102],"temporal":[103],"investigate":[106],"trends":[108],"Top":[110],"10":[111],"reported":[112,175],"AE":[113,126,187],"all":[115],"event":[118],"reports.":[119],"We":[120],"also":[121],"examined":[122],"similarity":[124],"across":[127,190],"diverse":[128],"regions":[129,170,191],"within":[130],"United":[132],"States.":[133],"Results":[134],"Our":[135],"findings":[136],"indicated":[137],"that":[138],"a":[139],"relatively":[140],"stably":[141],"decreasing":[142],"trend":[143],"was":[144],"observed":[145,189],"over":[146],"time,":[147],"with":[148,178],"four":[149],"peaks":[150],"December":[152],"2022,":[153],"February":[154],"2023,":[155],"Mar":[156],"2023":[157],"April":[159],"2023.":[160],"terms":[162],"spatial":[164],"analysis,":[165],"middle":[167],"northern":[169],"exhibited":[171],"higher":[172],"rates":[173],"AEs":[176],"associated":[177],"An":[182],"obvious":[183],"similar":[184],"pattern":[185],"is":[188],"(III,":[192],"IV,":[193],"V,":[194],"VI,":[195],"VII).":[196],"Conclusion":[197],"Overall,":[198],"research":[200],"underscores":[201],"ongoing":[203],"need":[204],"vigilant":[206],"post-licensure":[207],"vaccine":[208],"monitoring,":[209],"emphasizing":[210],"continuous":[212],"surveillance":[213],"essential":[216],"upholding":[218],"effectiveness":[222],"vaccines.":[226]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-03-04T00:00:00"}
